首页> 外文期刊>Clinical kidney journal >Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case-control study
【24h】

Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case-control study

机译:IGA肾病与血清ANCA积极性的临床特征:回顾性案例控制研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The coexistence of IgA nephropathy (IgAN) and antineutrophil cytoplasmic autoantibodies (ANCAs) is relatively rare. Only a few studies have reported the features of these patients. Methods: We studied the clinical and histological features of 20 ANCA-positive IgAN patients. They were compared with ANCA-negative IgAN patients (n = 40) and ANCA-associated systemic vasculitis (AASV) patients (n = 40) with a randomly selected and matched proportion of crescentic glomeruli. Furthermore, 9 ANCA-positive crescentic IgAN patients out of the 20 cases were compared with two control groups with crescentic nephritis. Results: ANCA-positive IgAN patients showed older age, lower haemoglobin and higher inflammatory indicator levels at baseline, and a higher percentage of general symptoms and pulmonary involvement, compared with ANCA-negative IgAN patients, and were comparable to AASV patients. Histologically, there was a significantly higher percentage of fibrinoid necrosis in glomeruli in ANCA-positive IgAN patients and in AASV patients compared with ANCA-negative IgAN patients (35,25 and 0%, respectively, P = 0.003). After immunosuppressive therapy, ANCA-positive crescentic IgAN patients were more likely to withdraw from dialysis (75 versus 9.1%, P = 0.03) and not to reach end-stage renal disease within 6 months (11.1 versus 66.7%, P = 0.01) compared with ANCA-negative crescentic IgAN patients. Conclusions: IgAN patients with ANCA positivity showed more severe clinical and histological features when compared with ANCA-negative IgAN patients and were comparable to AASV patients. However, renal prognosis was relatively better in ANCA-positive crescentic IgAN patients after aggressive immunosuppressive therapy in the short term, compared with ANCA-negative patients.
机译:背景:IgA肾病(IgAN)和抗嗜酸性能细胞质自身抗体(ANCAS)的共存相对罕见。只有一些研究报告了这些患者的特征。方法:研究了20例ANCA阳性IgAN患者的临床和组织学特征。将它们与ANCA阴性IgAN患者(N = 40)和ANCA相关的系统性血管炎(AASV)患者(N = 40)进行比较,随机选择和匹配的Cromescluli比例。此外,9例ANCA阳性新月状的IGAN患者与两种具有新月形肾炎的两种对照组进行比较。结果:ANCA阳性IGAN患者表现为年龄较大,血红蛋白和较高的基线炎症指标水平,与ANCA阴性IgAN患者相比,一般症状和肺部受累的百分比较高,并与AASV患者相媲美。组织学上,ANCA阳性IGAN患者和AASV患者的肾小球中纤维蛋白坏死百分比显着更高,与ANCA阴性IGAN患者(分别为3,25,25%,P = 0.003)。免疫抑制治疗后,ANCA阳性新月状的IGAN患者更容易退出透析(75对9.1%,P = 0.03),而不是在6个月内达到终末期肾病(11.1与66.7%,P = 0.01)相比用ANCA阴性新月形Igan患者。结论:与ANCA阴性IGAN患者相比,IgAN患者患有ANCA阳性的临床和组织学特征,并与AASV患者相媲美。然而,与ANCA阴性患者相比,在短期内发生侵袭性免疫抑制治疗后,肾脏预后在ANCA阳性新月形IgAN患者中相对较好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号